Announcements Trials
Browse Landscape

Phase

Phase 2 7Phase 3 6Phase 1/2 4Phase 1 3Phase 4 1

Status

Completed 3Unknown 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Plasma cell 4

Conditions

Prostatic Neoplasms 28Lymphoma, Large B-Cell, Diffuse 21Lymphoma 16Multiple Myeloma 10Lymphoma, Non-Hodgkin 10Lymphoma, Follicular 8Lymphoma, B-Cell 7Neoplasms 5Leukemia, Lymphocytic, Chronic, B-Cell 5Hodgkin Disease 5Burkitt Lymphoma 5Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 4Precursor Cell Lymphoblastic Leukemia-Lymphoma 4Neoplasms, Plasma Cell 4Lymphoma, Mantle-Cell 4Immunoblastic Lymphadenopathy 4Recurrence 3Lymphoma, T-Cell, Peripheral 3Lymphoma, Primary Effusion 3Lymphoma, Large-Cell, Anaplastic 3Lymphoma, B-Cell, Marginal Zone 3Leukemia 3Waldenstrom Macroglobulinemia 2Plasmablastic Lymphoma 2Neoplasm Metastasis 2Myelodysplastic Syndromes 2Metastatic Castration-resistant Prostate Cancer 2Lymphoma, T-Cell 2Hematologic Neoplasms 2Enteropathy-Associated T-Cell Lymphoma 2

Interventions

Melphalan 16Dexamethasone 15Bortezomib 11Peripheral Blood Stem Cell Transplantation 9Lenalidomide 9fludarabine phosphate 8Calcium Dobesilate 7pomalidomide 5fludarabine 5Busulfan 5carfilzomib 4Radiotherapy 4Prednisone 4Cyclophosphamide 4liposomal doxorubicin 3daratumumab 3Tacrolimus 3Mycophenolic Acid 3Methotrexate 3Filgrastim 3Cyclosporine 3Arsenic Trioxide 3Alemtuzumab 3samarium Sm-153 lexidronam 2holmium-1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetrakis(methylenephosphonic acid) 2Whole-Body Irradiation 2Surveys and Questionnaires 2Pneumococcal Vaccines 2Granulocyte Colony-Stimulating Factor 2Bendamustine Hydrochloride 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 1/2 × Neoplasms, Plasma Cell × Prednisone × Clear all
NCT00477750 2019-10-11

Melphalan, Prednisone, and Lenalidomide in Treating Patients With Newly Diagnosed Multiple Myeloma

Mayo Clinic

Phase 1/2 Completed
33 enrolled 14 charts
Plasma cell

Multiple Myeloma, Neoplasms, Plasma Cell

NCT00406978 2016-05-10

MPTD

University of Turin, Italy

Phase 1/2 Completed
24 enrolled
Plasma cell

Multiple Myeloma, Neoplasms, Plasma Cell

NCT01279694 2016-04-13

CARMYSAP

Nantes University Hospital

Phase 1/2 Completed
72 enrolled
Plasma cell

Neoplasms, Plasma Cell

NCT01002703 2011-08-12

Treatment With Lenalidomide, Bendamustine and Prednisone (RBP) in Patients With Relapsed or Refractory Multiple Myeloma

University of Leipzig

Phase 1/2 Unknown
50 enrolled
Plasma cell

Multiple Myeloma, Neoplasms, Plasma Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡